If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Fisher and Sons Regulatory News (FSJ)

Share Price Information for James Fisher and Sons (FSJ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 305.00
Bid: 296.00
Ask: 308.00
Change: 0.00 (0.00%)
Spread: 12.00 (4.054%)
Open: 305.00
High: 305.00
Low: 305.00
Prev. Close: 305.00
FSJ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Agreed Revolving Credit Facility

26 Apr 2023 07:00

RNS Number : 4493X
Fisher (James) & Sons plc
26 April 2023
 

This announcement contains inside information

26 April 2023

James Fisher and Sons plc

Agreed Revolving Credit Facility; Q1 ahead of prior year and in line with expectations

 

James Fisher and Sons plc (FSJ.L) ("James Fisher", the "Group"), the leading provider of marine services, announces that it has reached agreement on the terms of a new £210m secured revolving credit facility ("RCF"), which will be provided by its six existing lenders and which matures in March 2025.

 

The RCF will replace the Group's existing four facilities, which total £247.5m and of which £47.5m was due to mature in October 2023. The Group's successful programme of non-core disposals has resulted in continued deleveraging and the new RCF will provide the Group with continued financial flexibility to continue to execute its strategy. The Board is grateful for the expeditious support of its lenders and looks forward to concluding the long-form documentation of the RCF with a longstop date of 7 June 2023 (expected by mid-May and satisfaction of conditions shortly thereafter). The existing waiver in respect of the current £247.5m of borrowing facilities, which was granted following the JFN transaction, has been extended in line with the new RCF process to ensure continued access to funding.

 

The key terms of the new RCF are:

 

- a single, secured, multicurrency RCF facility of £210m with a maturity date of 31 March 2025

- scheduled amortisation requirements in line with the Group's deleveraging plans

- variable margin determined by the level of net leverage from time to time

- appropriate financial covenants, measured on a quarterly basis

 

The Group's FY22 results announcement is scheduled for 28 April 2023. The results for FY22 are in line with previous guidance provided on 24 March 2023 and the Group's trading performance in the first quarter of FY23 is ahead of prior year and in line with the Board's expectations.

 

Jean Vernet, Chief Executive Officer, commented:

 

"We are pleased to have reached this important agreement with our lenders and appreciate their ongoing support. We look forward to completing the final steps of the refinancing over the coming weeks. The Group has traded well in the first quarter of 2023 and we remain focused on delivering further financial and operational improvement."

 

 

For further information:

James Fisher and Sons plc

Jean Vernet

Duncan Kennedy

Chief Executive Officer

Chief Financial Officer

020 7614 9503

FTI Consulting

Richard Mountain

Susanne Yule

0203 727 1340

 

 

The person responsible for making this announcement on behalf of the Company is Jean-François Bauer, Group General Counsel.

 

LEI: 213800J975E5OYR6S216

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBCGDSCXDDGXU
Date   Source Headline
14th May 20204:41 pmRNSSecond Price Monitoring Extn
14th May 20204:36 pmRNSPrice Monitoring Extension
30th Apr 20202:51 pmRNSDisclosure of Rights Attached to Equity Shares
30th Apr 20202:49 pmRNSResult of AGM
30th Apr 20207:00 amRNSAGM trading statement & Covid-19 update
21st Apr 20209:00 amRNSHolding(s) in Company
15th Apr 20207:00 amRNSHolding(s) in Company
14th Apr 202010:20 amRNSDirector/PDMR Shareholding
1st Apr 20204:35 pmRNSPrice Monitoring Extension
31st Mar 20207:00 amRNSAnnual General Meeting and COVID-19
30th Mar 202012:08 pmRNSSecond Price Monitoring Extn
30th Mar 202012:03 pmRNSPrice Monitoring Extension
26th Mar 20207:00 amRNSCovid-19 Update
20th Mar 20205:30 pmRNSAnnual Report and Accounts posted
20th Mar 20204:45 pmRNSDirector/PDMR Shareholding
20th Mar 202010:20 amRNSSecond Price Monitoring Extn
20th Mar 202010:16 amRNSPrice Monitoring Extension
20th Mar 20207:00 amRNSDirectorate Change
18th Mar 202012:02 pmRNSPrice Monitoring Extension
18th Mar 202010:21 amRNSFinal dividend payment date
17th Mar 20203:57 pmRNSDirector/PDMR Shareholding
16th Mar 202012:07 pmRNSSecond Price Monitoring Extn
16th Mar 202012:02 pmRNSPrice Monitoring Extension
27th Feb 20204:41 pmRNSSecond Price Monitoring Extn
27th Feb 20204:36 pmRNSPrice Monitoring Extension
27th Feb 20207:00 amRNSFinal Results for the year ended 31 December 2019
21st Feb 20207:00 amRNSFour year contract extension worth £35m
13th Feb 202012:51 pmRNSDirector Shareholding Update
16th Jan 20203:40 pmRNSBLOCK LISTING SIX MONTHLY RETURN
9th Jan 202012:07 pmRNSSecond Price Monitoring Extn
9th Jan 202012:02 pmRNSPrice Monitoring Extension
9th Jan 202011:06 amRNSDirector/PDMR Shareholding
2nd Jan 202011:19 amRNSTotal Voting Rights
6th Dec 20199:35 amRNSTotal Voting Rights and Share Capital
28th Nov 20197:00 amRNSTrading Update
5th Nov 20191:29 pmRNSNotice of cyber security incident
2nd Oct 201911:39 amRNSTotal Voting Rights and Share Capital
1st Oct 20197:00 amRNSCONFIRMATION OF APPOINTMENT OF CEO
27th Sep 20197:00 amRNSSubmarine Rescue System contract
4th Sep 20192:38 pmRNSTotal Voting Rights
28th Aug 20197:00 amRNSHalf year results
7th Aug 20197:00 amRNSAcquisition of SM Continental S.A.
16th Jul 20197:00 amRNSContract Wins
5th Jul 20197:00 amRNSAppointment of new Chief Executive Officer
1st Jul 20199:49 amRNSTotal Voting Rights
19th Jun 201911:13 amRNSBLOCK LISTING SIX MONTHLY RETURN
10th Jun 20197:00 amRNSAdditional Listing
2nd May 20194:20 pmRNSResult of AGM
2nd May 20197:00 amRNSTrading Update & AGM Statement
26th Apr 20191:59 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.